APA (7th ed.) Citation

Uribe-Herranz, M., Beghi, S., Ruella, M., Parvathaneni, K., Salaris, S., Kostopoulos, N., . . . Facciabene, A. (2023). Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy. Molecular therapy, 31(3), 686-700. https://doi.org/10.1016/j.ymthe.2023.01.012

Chicago Style (17th ed.) Citation

Uribe-Herranz, Mireia, et al. "Modulation of the Gut Microbiota Engages Antigen Cross-presentation to Enhance Antitumor Effects of CAR T cell Immunotherapy." Molecular Therapy 31, no. 3 (2023): 686-700. https://doi.org/10.1016/j.ymthe.2023.01.012.

MLA (9th ed.) Citation

Uribe-Herranz, Mireia, et al. "Modulation of the Gut Microbiota Engages Antigen Cross-presentation to Enhance Antitumor Effects of CAR T cell Immunotherapy." Molecular Therapy, vol. 31, no. 3, 2023, pp. 686-700, https://doi.org/10.1016/j.ymthe.2023.01.012.